Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) General Information
Description
Rights to develop and commercialize praliciguat.
Contact Information
Corporate Office
- Cambridge, MA
- United States
Corporate Office
- Cambridge, MA
- United States
Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) FAQs
-
Where is Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) headquartered?
Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) is headquartered in Cambridge, MA.
-
What industry is Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) in?
Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat)’s primary industry is Buildings and Property.
-
Is Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) a private or public company?
Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) is a Private company.
-
What is the current valuation of Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat)?
The current valuation of Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) is .
-
What is Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat)’s current revenue?
The current revenue for Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) is .
-
Who are Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat)’s investors?
Cyclerion has invested in Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat).
-
When was Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) acquired?
Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) was acquired on 04-Jun-2021.
-
Who acquired Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat)?
Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) was acquired by Akebia Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process